MEDIFAST, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-2
Book Value Per Share
$18
Free Cash Flow Per Share
$0
Cash Per Share
$8
Revenue Per Share
$35
OCF Per Share
$1
Return on Equity
-9.1%
Return on Assets
-7.0%
Return on Invested Capital
-5.5%
Debt to Equity
—
Current Ratio
4.69
Quick Ratio
4.22
Asset Turnover
1.45
Days Sales Outstanding
—
Days Inventory On Hand
66.76
R&D / Revenue
1.1%
SBC / Revenue
2.0%
Capex / Revenue
1.5%
Working Capital
$159M
Net Current Asset Value
$153M
Invested Capital
$199M
OCF / Net Income
-0.37
FCF / Net Income
-0.07
Accruals Ratio (Sloan)
-10.3%
Net Debt
$-167M
Net Debt / EBITDA
-5768.03
Interest Coverage
-2.58
Cash Coverage
1.24
Dividend Coverage
35.19
Capex Coverage
1.22
Tangible Common Equity
$199M
TCE / Total Assets
80.2%
NOPAT
$-11M
Cash ROIC
0.6%
WC / Revenue
41.1%
Capex / D&A
0.39
Reinvestment Rate
60.7%
Total Payout Ratio
-1.0%
Asset Growth vs Revenue Growth
23.2%
Revenue 5Y CAGR
-16.2%
EPS 5Y CAGR
-51.5%
FCF 5Y CAGR
-61.0%
EBITDA 5Y CAGR
-81.6%
Book Value 5Y CAGR
4.8%
Stock Price (FY-end)
$11
Market Cap
$117M
P/E Ratio
92.38
P/S Ratio
0.30
P/B Ratio
0.59
P/TB Ratio
0.59
P/OCF Ratio
17.09
P/FCF Ratio
93.90
Enterprise Value
$-50M
EV / EBITDA
-1724.00
EV / Sales
-0.13
EV / FCF
-40.03
FCF Yield
1.1%
Dividend Yield
0.2%
Shareholder Yield
-6.3%
Buyback Yield
0.0%
R&D Yield
3.7%
Capex Yield
4.8%
Dividend Per Share
$0
DPS YoY Growth
-72.8%
Operating Leverage
2.23
Graham Number
$9
Shares Variation (YoY)
0.2%
Beta (5Y)
0.87
Cost of Equity
8.8%
Cost of Debt (after tax)
—
52W High
$18
52W Low
$10
Trailing Return 1Y
-39.3%
Trailing Return 5Y
-94.0%
F-Score (Piotroski)
3.00
M-Score (Beneish)
—
Z-Score (Altman)
4.46
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.